A retrospective, prospective, two-way cohort clinical study of kidney tonifying Chinese patent medicine on the growth and behavioral development of offspring after in vitro fertilization embryo tr

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2100005475

Enrollment

Unknown

Registered

2021-12-30

Start date

2021-12-20

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

1:Not applicable(participant s mother took patent TCM during ART)

2:Not applicable(participant s mother took matched placebo during ART)

Eligibility

Sex/Gender

All

Age

4 Years to 8 Years

Inclusion criteria

Inclusion criteria: (1)The offspring of subjects who participated in a randomized, double-blind, placebo-controlled, multi-center clinical study of Zishen Yutai pill used in in vitro fertilization-embryo transfer treatment; (2)The monthly age is 66±3 months or 78±3 months; (3)The guardian agrees to participate in this study and signs an informed consent form.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

Measure	Time frame
Behavior Scale Score;Gesell scale score (66±3 months subjects);Temperament scale score;Birth defect rate;Developmental indicators (height, weight, BMI, head circumference, chest circumference);Physical examination indicators;Webster's Intelligence Scale for Children (78±3 months of subjects);	—

Countries

China

Contacts

Public ContactXiaoli Chen

gzxiaolichen@163.com020-81332233

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026